Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BridgeBio
BridgeBio
Bayer pays $310M to buy into BridgeBio heart drug
BioPharma Dive
Mon, 03/4/24 - 11:52 am
BridgeBio
Bayer
acoramidis
Pfizer
Vyndamax
transthyretin amyloidosis cardiomyopathy
BridgeBio taps investors for $1.25B to fund showdown with Pfizer
Fierce Biotech
Thu, 01/18/24 - 11:00 am
BridgeBio
Pfizer
funding
ATTR
BridgeBio gears up for FDA review of acoramidis following Phase III results
Clinical Trials Arena
Thu, 01/11/24 - 11:07 am
BridgeBio
FDA
acoramidis
clinical trials
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Fierce Pharma
Mon, 09/18/23 - 08:01 pm
Pfizer
BridgeBio
Alnylam
FDA
clinical trials
ATTR-CM
physicians
tafamidis
BridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease Study
Marketwatch
Sun, 07/16/23 - 03:03 pm
BridgeBio
transthyretin amyloid cardiomyopathy
Why BridgeBio Pharma Stock Is Plunging Today
Motley Fool
Thu, 06/15/23 - 06:56 pm
BridgeBio
clinical trials
acoramidis
ATTR-CM
Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Albireo Pharma
Amryt Pharma
Apellis Pharmaceuticals
AstraZeneca
BridgeBio
Novo Nordisk
Pfizer
Protagonist Therapeutics
Provention Bio
Reata Pharmaceuticals
Regeneron
Sanofi
Seagen
BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia
BioSpace
Wed, 03/8/23 - 09:42 am
Biomarin
BridgeBio
achondroplasia
FDA
Voxzogo
BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study
Investors Business Daily
Mon, 03/6/23 - 11:09 am
BridgeBio
dwarfism
infigratinib
achondroplasia
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
$2.4B BridgeBio/Helsinn Liver Cancer Deal Falls Apart
BioSpace
Thu, 10/13/22 - 11:53 pm
BridgeBio
Helsinn
liver cancer
Truseltiq
BridgeBio's CEO on staying alive, 'motherhood and apple pie'
Fierce Biotech
Thu, 05/26/22 - 10:15 am
BridgeBio
layoffs
When will biotech markets get better? BridgeBio fears they may stay 'pretty bad' until 2024
Fierce Biotech
Tue, 05/24/22 - 10:49 am
BridgeBio
layoffs
biotech
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
Fierce Biotech
Fri, 05/13/22 - 10:50 am
BridgeBio
priority review vouchers
FDA
A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers
Endpoints
Thu, 05/12/22 - 10:24 am
BridgeBio
Bristol Myers Squibb
cancer
R&D
‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar
BioSpace
Wed, 04/27/22 - 10:59 am
Novartis
Nektar
BridgeBio
layoffs
restructuring
executives
BridgeBio says trial for acoramidis in transthyretin amyloidosis did not meet main goal
Seeking Alpha
Mon, 12/27/21 - 11:16 am
BridgeBio
acoramidis
clinical trials
transthyretin amyloidosis
Bridgebio sets its heart on besting Pfizer
EP Vantage
Fri, 12/3/21 - 10:31 am
BridgeBio
Pfizer
acoramidis
Vyndaqel
amyloidosis
transthyretin amyloid cardiomyopathy
BridgeBio Gets $750M on Credit to Fuel Long List of Programs
Pharma Live
Thu, 11/18/21 - 11:05 pm
BridgeBio
funding
research and development
Bristol Myers Squibb catches the SHP2 wave in a new collaboration deal with BridgeBio
Endpoints
Tue, 07/27/21 - 10:40 am
Bristol Myers Squibb
SHP2 inhibitors
Opdivo
BridgeBio
cancer
Pages
1
2
next ›
last »